Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.

Morten TulstrupThomas L FrandsenJonas AbrahamssonBendik LundKim VettenrantaOlafur Gisli JonssonHanne Vibeke Hansen MarquartBirgitte Klug AlbertsenMats HeymanKjeld Schmiegelow

Published in: European journal of haematology (2017)

This study found no benefit from individualized 6-mercaptopurine increments compared to standard therapy.

Keyphrases

acute lymphoblastic leukemia
randomized controlled trial
study protocol
allogeneic hematopoietic stem cell transplantation
stem cells
clinical trial
combination therapy
mesenchymal stem cells
bone marrow